B. Fisher, S. Anderson, J. Bryant et al., “Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer,” The New England Journal of Medicine, vol. 347, no. 16, pp. 1233–1241, 2002.
[2]
N. L. Simone, T. Dan, J. Shih, et al., “Twenty-five year results of the National Cancer Institute randomized breast conservation trial,” Breast Cancer Research and Treatment, vol. 132, no. 1, pp. 197–203, 2012.
[3]
U. Veronesi, N. Cascinelli, L. Mariani et al., “Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer,” The New England Journal of Medicine, vol. 347, no. 16, pp. 1227–1232, 2002.
[4]
S. E. Singletary, “Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy,” American Journal of Surgery, vol. 184, no. 5, pp. 383–393, 2002.
[5]
M. Morrow, J. R. Harris, and S. J. Schnitt, “Surgical margins in lumpectomy for breast cancer, bigger is not better,” The New England Journal of Medicine, vol. 367, pp. 79–82, 2012.
[6]
P. J. Lovrics, S. D. Cornacchi, F. Farrokhyar et al., “The relationship between surgical factors and margin status after breast-conservation surgery for early stage breast cancer,” American Journal of Surgery, vol. 197, no. 6, pp. 740–746, 2009.
[7]
T. Tot, “The theory of the sick breast lobe and the possible consequences,” International Journal of Surgical Pathology, vol. 15, no. 4, pp. 369–375, 2007.
[8]
W. C. Dooley, “Breast ductoscopy and the evolution of the intra-ductal approach to breast cancer,” The Breast Journal, vol. 15, supplement 1, pp. S90–S94, 2009.
